Michael Verneris
University of Colorado Denver
H-index: 67
North America-United States
Top articles of Michael Verneris
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Establishing Costs for Commercial Chimeric Antigen Receptor T-Cell (Tisagenlecleucel; Kymriah) in Children and Young Adult B-Cell Acute Lymphoblastic Leukemia: A Merged … | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Prakash Satwani Karen Chao Maria Lopez-Garcia Matt Hall Zhezhen Jin | 2024/2/1 |
Risk Factors for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Kevin Owen McNerney Vanessa A Fabrizio Aimee C Talleur Stephanie Si Lim Alexandra Dreyzin | 2024/2/1 |
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional … | Nature Communications | Michael D Keller Patrick J Hanley Yueh-Yun Chi Paibel Aguayo-Hiraldo Christopher C Dvorak | 2024/4/18 |
Adenoviral Cellular Therapy with Adenovirus (ADV)-Specific Cytotoxic T-Lymphocytes (CTLs) for Resistant Infections in Children, Adolescent, and Young Adult (CAYA) Patients … | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Edo Schaefer Christine Vu Allyson Flower Janet Ayello Yaya Chu | 2024/2/1 |
Success of Centralized Manufacturing of CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML | Transplantation and Cellular Therapy | Brian Bowser Xiaoyi Yang John Roach Julie Blake Kate Donnelly | 2024/2/1 |
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity | Cancer Immunology, Immunotherapy | Jennifer W Cao Jessica Lake Renata Impastato Lyndah Chow Luisanny Perez | 2024/3/30 |
Single cell RNA-sequencing of Ewing sarcoma tumors demonstrates transcriptional heterogeneity and clonal evolution. | bioRxiv | Andrew Goodspeed Avery Bodlak Sarah Nelson-Taylor Naoki Oike Ryota Shirai | 2024 |
Development of a Safety Surveillance Plan for The Academic Medicine Sponsor Performing First in Human Cellular Therapy Clinical Trials: A Report from the Consortium for … | Cheri Adams Michael Keller Jennifer G Michlitsch Paibel Aguayo-Hiraldo Karin Chen | 2024/3/4 | |
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia | Transplantation and Cellular Therapy | Kevin O McNerney Amy Moskop Lena E Winestone Christina Baggott Julie-An Talano | 2024/1/1 |
Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment | Frontiers in Immunology | Joselyn Cruz Cruz Kristen C Allison Lauren S Page Alexis J Jenkins Xiaodong Wang | 2023/3/7 |
Outcomes after nonresponse and relapse post-tisagenlecleucel in children, adolescents, and young adults with B-cell acute lymphoblastic leukemia | Journal of Clinical Oncology | Liora M Schultz Anne Eaton Christina Baggott Jenna Rossoff Snehit Prabhu | 2023/1/10 |
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world … | EClinicalMedicine | Valentin Barsan Yimei Li Snehit Prabhu Christina Baggott Khanh Nguyen | 2023/11/1 |
Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia | Blood | Kevin O McNerney Vanessa A Fabrizio Aimee C Talleur Stephanie Si Lim Alexandra Dreyzin | 2023/11/28 |
Time to transplantation and pediatric acute myeloid leukemia outcomes | Bone Marrow Transplantation | Lindsey A Murphy Kristen Miller Amanda C Winters Anna RK Franklin Michael R Verneris | 2023/3 |
frontiers REVIEW in Oncology published: 14 December 2020 | The Characteristics of Pediatric Soft Tissue Sarcomas: Recent Advances in Management and Treatment | Alan Wayne Rosandra Natasha Kaplan Shahab Asgharzadeh Alisa B Lee-Sherick Sarcoma Tumor Microenvironment | 2023/8/31 |
Treatment of Refractory Adenovirus (ADV) Infections Using Adv-Specific Cytotoxic T-Lymphocytes (CTLs) in Children, Adolescents and Young Adults (CAYA) Post Allogeneic … | Blood | Edo Schaefer Christine Vu Allyson Flower Janet Ayello Yaya Chu | 2023/11/28 |
Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease? | British Journal of Haematology | Laura McLaughlin Edwin DeZoeten Michael R Verneris | 2023/3 |
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL | Blood advances | Kevin O McNerney Stephanie J Si Lim Kyle Ishikawa Alexandra Dreyzin Anant Vatsayan | 2023/6/27 |
Compositions and methods for producing and using ilcs to treat health conditions | 2023/11/9 | ||
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium | Blood advances | Heather E Stefanski Anne Eaton Christina Baggott Jenna Rossoff Michael R Verneris | 2023/2/28 |
